]>
IRCT20230509058136N1 IRCT 2023-05-11 Esfahan University of Medical Sciences Dienogest and OCPs on endometriosis-related pain A comparative study of the effect of Dienogest and OCP on endometriosis-related pain and endometrioma size 2023-06-22 anticipated 100 Complete https://irct.ir/trial/70059 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization was done with the help of random number generation program. A number of envelopes were determined according to the number of people in the study, and each sequence of numbers created by the program was placed in each envelope and the envelopes were closed. Then an envelope was opened according to the order of entry of the participants and the number inside was shown. If the production number is odd, the patient is placed in the first group, and if the number is even, the patient is placed in the second group. 2-3 ENDOMETRIOSIS. Intervention 1: Intervention group: Treatment with Dienogest 2 mg tablets made by Aburihan company one per day and daily for up to 1 year. Intervention 2: Intervention group: Treatment with LD drug made by Aburihan company on a daily basis and once a day for up to 1 year. No - There is not a plan to make this available Justification or reason for not sharing IPD is no more information
public Niloofar Ashtari
Hezar Jarib
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0048 ashtarimedical@gmail.com Esfahan University of Medical Sciences scientific Niloofar Ashtari
Hezar Jarib
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0048 ashtarimedical@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) age 16 to 40 sonography indicating endometriosis informed consent no intention of pregnancy 18 years 40 years Female intention of pregnancy without informed consent N80 Endometriosis Treatment - Drugs Treatment - Drugs Intervention group: Treatment with Dienogest 2 mg tablets made by Aburihan company one per day and daily for up to 1 year. Intervention group: Treatment with LD drug made by Aburihan company on a daily basis and once a day for up to 1 year Pain. Timepoint: 3 month, 6 month and 12 month after. Method of measurement: visual analoug scale. Esfahan University of Medical Sciences Approved 2022-06-01 Ethics committee of Isfahan University of Medical Sciences Hezar Jarib Isfahan Isfehan Iran (Islamic Republic of)